S. Koeppen

发表

J. Heimans, T. Postma, D. Strumberg, 2005, Neurology.

A Preliminary, Randomized, Multicenter Study Comparing Intravenous Immunoglobulin, Plasma Exchange, and Immune Adsorption in Guillain-Barré Syndrome

H. Diener, F. Rosenow, W. Haupt, 2001, European Neurology.

Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression

Raymond Y Huang, J. Olson, P. Wen, 2018, Neuro-oncology.

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.

M. Weller, C. Marosi, R. Soffietti, 2016, Neuro-oncology.

Neurological complications after cadaveric and living donor liver transplantation

Z. Katsarava, M. Malago', C. Broelsch, 2006, Journal of Neurology.

Lack of neuroprotection by an ACTH (4–9) analogue. A randomized trial in patients treated with vincristine for Hodgkin’s or non-Hodgkin’s lymphoma

H. Diener, J. Heimans, T. Postma, 2004, Journal of Cancer Research and Clinical Oncology.

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.

T. Postma, M. Valsecchi, G. Cavaletti, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term outcome of Guillain-Barré syndrome

H. Diener, C. Weimar, M. Schürks, 2006, Neurocritical care.

Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity

T. Postma, M. Valsecchi, L. Padua, 2019, Journal of the peripheral nervous system : JPNS.

Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016)

T. Postma, A. Schenone, C. Briani, 2013 .

Muscle force and fatigue in patients with sepsis and multiorgan failure

M. Neuhäuser, M. Gerwig, M. Eikermann, 2006, Intensive Care Medicine.

Ambulatory norepinephrine treatment of severe autonomic orthostatic hypotension.

R. Erbel, A. Kribben, A. Mitchell, 2001, Journal of the American College of Cardiology.

Neuromuscular complications after hematopoietic stem cell transplantation

S. Koeppen, M. Koldehoff, A. Thirugnanasambanthan, 2014, Supportive Care in Cancer.

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.

G. Reifenberger, M. Weller, C. Meisner, 2015, Neuro-oncology.

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.

G. Reifenberger, M. Weller, A. von Deimling, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

G. Reifenberger, M. Weller, C. Meisner, 2013, Neurology.

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

J. Heimans, G. Altavilla, T. Postma, 2013 .

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

G. Altavilla, T. Postma, S. Galimberti, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Neurologic complications in adult living donor liver transplant patients: an underestimated factor?

V. Cicinnati, S. Beckebaum, S. Nadalin, 2009, Journal of Neurology.

Late onset of tacrolimus‐related posterior leukoencephalopathy after living donor liver transplantation

T. Egelhof, G. Stavrou, S. Nadalin, 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Treatment of Multiple Myeloma: Thalidomide-, Bortezomib-, and Lenalidomide-Induced Peripheral Neuropathy

S. Koeppen, 2014, Oncology Research and Treatment.

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.

D. Strumberg, S. Seeber, M. Scheulen, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

New-onset Parkinson syndrome after liver transplantation.

A. Paul, S. Koeppen, F. Saner, 2012, Transplantation.

[Neurocysticercosis. Current review of the literature based on a long-term study of 2 clinically distinct German cases].

F. Wiegand, P. Häussermann, A. Delcker, 1999, Der Nervenarzt.

Is stereotactic biopsy a reliable method to differentiate tumor from radiation necrosis?

M. Maschke, A. Dörfler, S. Koeppen, 2002, Clinical neuropathology.

Management options for established chemotherapy-induced peripheral neuropathy

Y. T. Cheung, P. Jean-Pierre, C. Loprinzi, 2014, Supportive Care in Cancer.

Y. T. Cheung, C. Loprinzi, A. Chan, 2020, Supportive Care in Cancer.

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

J. Heimans, G. Altavilla, T. Postma, 2013, European journal of cancer.

Progressive multifocal leukoencephalopathy: Neurological findings and evaluation of magnetic resonance imaging and computed tomography

S. Koeppen, H. Lehmann, 2005, Neurosurgical Review.

Diagnostic value of segmental somatosensory evoked potentials in cases with chronic progressive para- or tetraspastic syndromes.

S. Koeppen, J. Jörg, W. Düllberg, 1982, Advances in neurology.

Ambulatory Infusion of Noradrenaline for Long-Term Treatment of Shy-Drager Syndrome

A. Kribben, S. Koeppen, T. Philipp, 1998, Kidney and Blood Pressure Research.

Paraneoplastic cerebal venous and sinus thrombosis

S. Koeppen, O. Kastrup, H. Diener, 1996 .

CI‐PERINOMS: chemotherapy‐induced peripheral neuropathy outcome measures study

G. Stragliotto, T. Postma, S. Galimberti, 2009, Journal of the peripheral nervous system : JPNS.

Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity

G. Cavaletti, A. Schenone, C. Briani, 2021, Neurology.

H. Kaube, P. Mummel, S. Koeppen, 2000, Journal of neurology, neurosurgery, and psychiatry.

NEURO/MEDICAL ONCOLOGY

Scott N. Hwang, Katrina H. Smith, Susan M. Chang, 2013 .

Myopathy in two siblings with nephropathic cystinosis

H. Diener, M. Keidel, S. Koeppen, 1998, European journal of neurology.

Correspondence between neurophysiological and clinical measurements of chemotherapy‐induced peripheral neuropathy: secondary analysis of data from the CI‐PeriNomS study

M. Johantgen, T. Postma, M. Valsecchi, 2014, Journal of the peripheral nervous system : JPNS.

Electrically evoked nociceptive potentials for early detection of diabetic small‐fiber neuropathy

H-C Diener, H. Kaube, Z. Katsarava, 2010, European journal of neurology.

Treatment of central pontine myelinolysis with plasmapheresis and immunoglobulins in liver transplant patient

S. Herget-Rosenthal, C. Broelsch, A. Radtke, 2008, Transplant international : official journal of the European Society for Organ Transplantation.

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

T. Postma, G. Cavaletti, A. Schenone, 2013, Annals of Oncology.

Treatment of Multiple Myeloma: Thalidomide-, Bortezomib-, and Lenalidomide-Induced Peripheral Neuropathy

S. Koeppen, 2014, Oncology Research and Treatment.